Table 1.
Characteristics of subjects with and without metabolic syndrome.
| All | With metabolic syndrome | Without metabolic syndrome | P value | |
|---|---|---|---|---|
| (n = 29,797) | (n = 8564) | (n = 21,233) | ||
| BMI, kg/m2∗ | 23.81 ± 3.58 | 26.23 ± 3.31 | 22.84 ± 3.21 | <0.001 |
| Age, years∗ | 52.2 ± 13.3 | 56.3 ± 12.5 | 50.6 ± 13.2 | <0.001 |
| Sex (M/F) (%) | 16,098/13,699 | 6525/2039 | 9573/11,660 | <0.001 |
| (54.0/46.0) | (76.2/23.8) | (45.1/54.9) | ||
| WC, cm∗ | 83.8 ± 10.3 | 91.5 ± 8.4 | 80.7 ± 9.3 | <0.001 |
| SBP, mmHg∗ | 124.3 ± 18.6 | 134.9 ± 17.2 | 120.0 ± 17.4 | <0.001 |
| DBP, mmHg∗ | 77.5 ± 14.3 | 83.7 ± 17.5 | 75.0 ± 11.8 | <0.001 |
| Fasting glucose, mg/dL∗ | 95.5 ± 24.8 | 110.4 ± 35.3 | 89.5 ± 15.3 | <0.001 |
| Cholesterol, mg/dL∗ | 199.2 ± 37.0 | 203.1 ± 38.1 | 197.6 ± 36.5 | <0.001 |
| HDL, mg/dL∗ | 53.7 ± 15.0 | 42.9 ± 10.12 | 58.0 ± 14.5 | <0.001 |
| LDL, mg/dL∗ | 125.3 ± 32.9 | 129.0 ± 33.3 | 123.8 ± 32.6 | <0.001 |
| TG, mg/dL∗ | 130.4 ± 88.1 | 201.3 ± 111.5 | 101.8 ± 55.1 | <0.001 |
| AST, IU/L∗ | 23.1 ± 13.2 | 26.0 ± 18.2 | 21.9 ± 10.3 | <0.001 |
| ALT, IU/L∗ | 27.0 ± 22.2 | 35.1 ± 29.1 | 23.8 ± 17.6 | <0.001 |
| GGT, IU/L∗ | 24.8 ± 36.8 | 34.2 ± 50.9 | 21.0 ± 28.4 | <0.001 |
| Platelet, 1000/mm3∗ | 249.8 ± 60.3 | 247.5 ± 62.0 | 250.8 ± 59.6 | <0.001 |
| Fatty liver (yes/no) (%) | 13,255/16,542 | 6295/2269 | 6960/14,273 | <0.001 |
| (44.5/55.5) | (73.5/26.5) | (32.8/67.2) | ||
| FLI | 27.24 ± 24.18 | 50.22 ± 22.81 | 17.97 ± 17.65 | <0.001 |
| LAP | 35.28 ± 33.59 | 64.22 ± 43.52 | 23.61 ± 18.57 | <0.001 |
∗Expressed as mean ± standard deviation.
BMI, body mass index; M, male; F, female; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase; FLI, fatty liver index; LAP, lipid accumulation product.